Genmab A/S Sponsored ADR (GMAB) vs Moderna, Inc. (MRNA)

• Genmab A/S Sponsored ADR GMAB 57.06 ▲ +1.01%
• Moderna, Inc. MRNA 221.72 ▼ −0.47%

Genmab A/S Sponsored ADR and Moderna, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $88.9B against $33.8B — 2.6× the size. Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; Genmab A/S Sponsored ADR trades at 44.9×. Genmab A/S Sponsored ADR grew revenue faster over the last twelve months: 22.3% against −27.6%. Genmab A/S Sponsored ADR has the higher net margin (19.1% vs −141.4%) and the higher return on invested capital (6.99% vs −93.5%). Across the 19 metrics below, Genmab A/S Sponsored ADR leads on 13 and Moderna, Inc. on 6.